Rite-Aid: We Just Don't Know

When I initiated coverage on Walgreens Boots Alliance (NASDAQ:WBA), I spoke about its success as a company. I also went on to discuss the Rite Aid (NYSE:RAD) acquisition. The truth is that we simply just do not know how accretive the deal will be. While the Rite Aid acquisition was approved by shareholders, some have claimed the deal is dead. The companies together divested 500 stores in order to get federal permission on the merger. While we just do not know the impact, if the deal goes through, which is on track for by the end of the year, my inclination is that like any other major merger, at first, the deal will be costly as the processes are integrated, stores are closed, employees moved, etc. Then, say a year or so later, things will be accretive, especially if WBA can cut the selling and administrative expenses. We will see. But, of course, Rite-Aid's operations need to be earnings/cash flow positive to be accretive. So, on that note, I want to discuss Rite Aid's just reported results.

Well, in fiscal Q2 2017, the company saw revenues of $8.03 billion, which missed estimates by $60 million. However, these were up 5% year over year. Now, in addition to the sales miss, there was an in line results on earnings. Net income came in at a loss of $14.8 million, or $0.01 per diluted share. On an adjusted basis, adjusted net income was $21.5 million, or $0.02 per share, while adjusted EBITDA was $313 million, or 3.9% of revenues. It's important to note that both adjusted EBITDA and net earnings were down markedly from last year. What gives?

READ FULL ARTICLE HERE